Medical Grand Rounds - "Monkeypox"

Friday, September 9, 2022 | 12 p.m. - 1 p.m.
Microsoft Teams

Presenter: David J. Cennimo, MD, FACP, FAAP, AAHIVS, Associate Professor of Medicine-Pediatrics, Department of Infectious Disease; Associate Program Director, Internal Medicine and Pediatrics Residency Program; and Associate Dean of Education, Rutgers New Jersey Medical School

At the conclusion of this activity, participants should be able to:

  1. Recognize the clinical spectrum of illness seen in Human Monkeypox infection.
  2. Review infection control practices.
  3. Counsel patients on the risk of Human Monkeypox and ways to decrease infection risk.
  4. Review currently used treatment and prevention of Monkeypox.

*NOTE: #4 is not FDA approved; still under IND (investigational new drug)

Date, Time & Location:

Friday, September 9, 2022 at 12:00 p.m.
Microsoft Teams - E-mail Trish.Stern@guthrie.org to be included

This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Professionals.

Accreditation Statement
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”
Designation Statement
“The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
Disclosure Statement
“Faculty and all others who have the ability to control the content of continuing medical education activities provided by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent relevant financial relationships related to this educational activity.” “The presenting faculty/planning committee for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”